Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apoptosis: a novel therapeutic tool?

S C Dixon1, I N Arah

  • 1Medicine Branch, Clinical Pharmacokinetics Unit, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. nemra@box-n.nih.gov

Expert Opinion on Investigational Drugs
|July 5, 2005
PubMed
Summary

Apoptosis, or programmed cell death, is vital for health. Restoring the balance between cell death and proliferation, potentially with genetic approaches, offers new therapeutic strategies for diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.

British journal of cancer·2015
Same author

Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survival.

Gynecologic oncology·2013
Same author

Resistance to growth inhibitory and apoptotic effects of phorbol ester and UCN-01 in aggressive cancer cell lines.

International journal of oncology·2001
Same author

The control of prostate-specific antigen expression and gene regulation by pharmacological agents.

Pharmacological reviews·2001
Same author

Efficacy of microtubule-active drugs followed by ketoconazole in human metastatic prostate cancer cell lines.

The Journal of urology·2000
Same author

Endostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay.

Biochemical and biophysical research communications·2000

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Apoptosis is a fundamental, genetically programmed cell death process essential for multicellular organism homeostasis.
  • Disruptions in the balance between cell proliferation and apoptosis are implicated in various diseases.
  • Understanding apoptosis pathways is crucial for developing targeted disease therapies.

Purpose of the Study:

  • To explore the molecular mechanisms of apoptosis.
  • To identify potential therapeutic interventions for diseases involving apoptosis dysregulation.
  • To investigate the efficacy and safety of genetic approaches in modulating apoptosis.

Main Methods:

  • Analysis of molecular mechanisms underlying apoptosis.
  • Review of existing therapeutic agents (chemo-, radio-, cytokine therapy).
  • Evaluation of novel genetic approaches in in vitro and animal models.

Main Results:

  • Detailed understanding of apoptosis molecular pathways has emerged.
  • Current therapies show partial success, with remaining challenges in drug-resistant cells.
  • Genetic interventions demonstrate significant success in preclinical models with low toxicity.

Conclusions:

  • Restoring the equilibrium between cell proliferation and death is a key therapeutic goal.
  • Genetic approaches offer a promising, low-toxicity strategy to enhance existing therapies.
  • Combining traditional treatments with genetic interventions may significantly improve therapeutic efficacy and reduce resistance.

Related Experiment Videos